General Information
Version
6.11
Revision date
2025-04-23
Product name
Palmitoyl chloride for synthesis
CAS No.
112-67-4
REACH No
is
1.2.1 Relevant identified uses
Chemical for synthesis
Icons in SDS
Company Information
company name
Merck Pty Ltd
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H312, H315, H317
Hazard statements
Code
Statements
H312
Harmful in contact with skin
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Acute toxicity, (Category 4) H312: Harmful in contact with skin. Skin irritation, (Category 2) H315: Causes skin irritation. Skin sensitization, (Category 1) H317: May cause an allergic skin reaction.
2.2 Label elements
Labelling
Signal word
Warning Warning
Hazard statements
H312 Harmful in contact with skin. H315 Causes skin irritation. H317 May cause an allergic skin reaction. H317 May cause an allergic skin reaction.
Precautionary statements
P261 Avoid breathing mist or vapors. P264 Wash skin thoroughly after handling. P272 Contaminated work clothing should not be allowed out of the workplace. P280 Wear protective gloves/ protective clothing. P302 + P352 + P312 IF ON SKIN: Wash with plenty of water.Call a POISON CENTER/ doctor if you feel unwell. P333 + P313 If skin irritation or rash occurs: Get medical advice/ attention. P261 Avoid breathing mist or vapors. P272 Contaminated work clothing should not be allowed out of the workplace. P333 + P313 If skin irritation or rash occurs: Get medical advice/ attention.
Supplemental label elements
none Reduced Labeling (<= 125 ml) none
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
